Quench Medical is developing a novel aerosol platform technology to deliver medicine into deep areas of the lung with unprecedented efficiency to greatly increase efficacy in treating pulmonary airway diseases. The primary application of this technology is an inhaled chemotherapy medication to treat lung cancer by directly targeting lung tumors and minimizing systemic toxicity. The platform technology is being extended with further pipeline medications to treat additional lung diseases such as COPD, asthma, and cystic fibrosis.